Hangzhou Alltest Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	294.76	302.47	180.58	1,185	765.69	679.23
Depreciation & Amortization	32.33	32.33	39.63	58	15.59	4.03
Other Amortization	10.28	10.28	10.13	6.95	2.13	1.34
Loss (Gain) From Sale of Assets	-1.22	-1.22	0.44	-0.53	0.06	-
Asset Writedown & Restructuring Costs	0.01	0.01	-0.6	74.72	0.02	0.04
Loss (Gain) From Sale of Investments	-57.09	-57.09	-57.25	-33.49	-28.28	-5.19
Provision & Write-off of Bad Debts	7.87	7.87	11.33	7.82	4.08	4.51
Other Operating Activities	-52.93	16.61	5.12	202.81	11.46	2.67
Change in Accounts Receivable	-52.12	-52.12	-14.05	129.53	-124.24	-90.37
Change in Inventory	19.26	19.26	12.4	-13.2	-264.05	-71.85
Change in Accounts Payable	28.91	28.91	-199.9	-221.75	537.97	100.47
Change in Other Net Operating Assets	14.23	14.23	20.69	11.45	-	-
Operating Cash Flow	252.26	329.52	24.76	1,361	923.87	622.72
Operating Cash Flow Growth	-16.05%	1230.66%	-98.18%	47.28%	48.36%	580.32%
Capital Expenditures	-201.93	-220.65	-533.49	-270.24	-140.12	-37.11
Sale of Property, Plant & Equipment	5.29	1.69	0.29	0.02	0.02	-
Cash Acquisitions	-	-	-	-16.61	-	-
Investment in Securities	-77.19	-267.07	363.81	-1,001	-398.2	-353
Other Investing Activities	25.89	6.97	28.72	24.01	6.95	5.19
Investing Cash Flow	-247.94	-479.06	-140.67	-1,264	-531.35	-384.92
Long-Term Debt Repaid	-	-5.66	-16.39	-115.56	-12.65	-
Net Debt Issued (Repaid)	-5.66	-5.66	-16.39	-115.56	-12.65	-
Issuance of Common Stock	8.57	8.57	8.74	-	1,680	-
Repurchase of Common Stock	-36.93	-36.93	-22.64	-34.44	-	-
Common Dividends Paid	-233.17	-232.66	-528.7	-215.62	-107.81	-
Other Financing Activities	41.75	-6.05	0.2	3.7	-39.37	-6.75
Financing Cash Flow	-225.44	-272.73	-558.79	-361.91	1,520	-6.75
Foreign Exchange Rate Adjustments	5.92	5.98	9.48	67.86	-18.72	-8.43
Net Cash Flow	-215.2	-416.29	-665.22	-197.36	1,894	222.61
Free Cash Flow	50.33	108.87	-508.73	1,090	783.75	585.61
Free Cash Flow Growth	-4.65%	-	-	39.13%	33.84%	666.06%
Free Cash Flow Margin	5.71%	12.56%	-67.41%	32.18%	41.84%	51.57%
Free Cash Flow Per Share	0.64	1.38	-6.42	13.76	10.48	9.80
Cash Income Tax Paid	11.59	8.11	15.37	85.85	65.73	50.44
Levered Free Cash Flow	-49.02	10.23	-647.33	792.39	532.31	399.02
Unlevered Free Cash Flow	-48.85	10.49	-646.42	793.75	532.72	399.02
Change in Working Capital	18.26	18.26	-164.61	-140.52	153.12	-63.91

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.